 |
 |
 |
Application for NGFN-2
KG: Infection and Inflammation
SIPAGE
"From Pathogen-Induced Signatures to Therapeutic Target Gens: Comparative
and Functional Analysis of the Inflammatory Response in Health and Disease"
Relevant patents filed or issued over the past five years
| Professor Trinad Chakraborty |
TGC
method for inducting targeted somatic transgenesis.
Von Eichel-Streiber, Chr.; Chakraborty, T. CA000002315216A1, 17.06.1999,
DE000019754938A1, 24.06.1999, WO001999029884A3, 12.08.1999, EP000001023453A2,
02.08.2000, AU000000751517B, 15.08.2002
Listeria
monocytogenes genome, polypeptides and uses.
Dominguez-Bernal, G.; Glaser, P.; Vazquez-Boland, J.A; Perez-Diaz, J.C.;
Entian, K.-D.; Berche, P.; Baquero, F.; Hauf, J.; Hain, T. ; Gomez-Lopez,
N. ; Kaerst, U.; Garcia del Portillo, F., Chakraborty, T.; Chetouani,
F.; Domann, E.; Maduenio, E.; Dussurget, O.; Kreft, J.; Goebel, W. ; Rose,
M.; Kunst, F.; Ng, E.; De Pablos, B.; Cossart, P.; Nedjari, H.; Wehland,
J.; Kuhn, M.; Daniels, J.; Buchrieser, C.; Garrido-Garcia, P.; Charbit,
A.; Couve, E.; Frangeul, L.; Amend, A.; Tierrez-Martinez, A.; Durant,
L.; Fsihi, H.; Rusniok, Chr.; Dehoux, P., Voss, H. CA000002404988A1, 18.10.2001
Method
for the determination of pathogenic Listeria bacteria.
Chakraborty, T.; Goebel, W.; Notermans, SHW. CA000002025566C, 18.06.2002
Screening
Assay zur Bewertung des Potentials von Verbindungen, die gegen eine Infektion
mit Listeria monocytogenes wirksam sind.
Heinz, D.; Wehland, J; Schubert, W.-D.; Domann, E., Chakraborty, T.
DE000010218396A1. 17.07.2003.
Recombinant
attenuated Listerias for immunotherapy.
Schadendorf, D.; Paschen, A.; Chakraborty, T.; Domann, E.
WO002001027295A1, 19.04.2001, DE000019949594A1 26.04.2001, EP000001228224A1
07.08.2002.
Attenuated
Salmonella strain used as a vehicle for oral immunization.
Darji, A.; Guzm, N., Carlos, C.; Timmis, K.; Wehland, J.; Weiss, S.; Gerstel,
B.; Chakraborty, T.; Wachholz, P. EP000000977874A1, 09.02.2000,
US020030180320A1, 25.09.2003.
Detection
of diarrhoeogenic E. coli germs.
Chakraborty, T.; Teigelkamp, St.; Ebel, F.; Scheefers-Borchel,
U.; Scheefers, H.
DE 200101174, 04.10.2001, WO002001073440A3, 30.05.2002
| Professor Ingo Autenrieth |
Patent
Nr. 00985048.8-2402 (EPA) 16.11.2000 "Test von Mikroorganismen"
DE 19955303. Heesemann, Autenrieth et al
Patent Nr. 103 51 627.1 November 2003, "Modulation der Angiogenese
durch Bartonella henselae. Kempf, Autenrieth
PCT/EP99/03527 WO/Wwvo (2003). Haas, R. and Trebesius, K.-H. Nachweis
von Antiobiotikaresistenzen in Mikroorganismen Europäische Patentanmeldung
Europäisches Patent 12208P EP-WO/Wwgo (2003) Haas, R et al.
Verfahren zur Identifizierung sekretorischer Gene aus Helicobacter pylori
| Professor Hermann Wagner |
| No. | Title |
|
EP 97 10 1019.4 |
Pharmaceutical compositions comprising a polynucleotide and optionally an antigen especially for vaccination |
| PCT/IB99/01285US Serial No. 09/241 653 | Methods for regulating hematopoiesis using CpG-Oligonucleotides |
| PCT/EP/9906502US Serial No. 09/786 436 | G-motif oligonucleotides and uses thereof |
| US Serial No.10/212 133 | Methods and compositions relating to plasmacytoid dendritic cells |
| EP00 128 634.3 | Reversible MHC multimer staining for functional purification of antigen-specific T-cells |
| US Serial No.09/594.987 | Process for high throughput screening of CpG-based immuno-agonist/antagonist |
| US Serial No. 60/396 432 | Use of CpG nucleic acids in prion disease |
| US Serial No. 10/407 952 | Immunostimulatory G,U-Containing oligoribonucleotides |
| new application | Methods and products for enhancing immune responses using Imidazoquinoline compounds |
| new application | Poly-D as carrier platform for antigen and immunostimulatory agonist and antagonist |
| new application | Cell-free methods for identifying compounds that affect toll-like receptor 9 (TLS9) signaling |
|
Professor
Rudolf Balling
|
Reversible
MHC multimers (Streptamers) - Dirk H. Busch and H. Wagner
| Dr. Thomas Häupl |
1. Häupl, T.; Ungethüm, U.; Bläß, S. 2002; Werkzeuge zur Diagnostik, molekularen Definition und Therapieentwicklung chronischer entzündlicher Gelenkerkrankungen; DE000010127572A1
2. Stuhlmüller, B.; Häupl, T. 2003; Nucleic acid array; EP000001310567A2
3. Stuhlmüller, B.; Häupl, T.; Kiesslich, O.; Burmester, G. R. 2003; Nukleinsäure-Array; DE000010155600A1
4. Paulitschke, M.; Bernstein, T.; Häupl, T.; 2000; Versatile cell and tissue culture chamber with improved sealing and bubble exclusion; DE000019817524C1
5. Häupl, T.; Kaps, C.; Sittinger, M.; Smolian, H. 2002; In vitro Zellinteraktionskultursystem für Medikamententestung und -Entwicklung; DE000010105420A1
6. Sittinger, M.; Schultz, O.; Burmester, G. R.; Häupl, T. 2000; Artificial tissues, methods for the production and the use thereof; US000006143501A
7. Häupl, T.; Kaps, C.; Sittinger, M.; Smolian, H. 2002; An in vitro cell interaction culture system for testing and developing medicaments; WO002002061420A3